Hallucinogenic herb a problem in Wash.

Feb 26, 2007

Both Washington state and U.S. officials are growing increasingly concerned over the popularity of a legal hallucinogenic herb in the region around Seattle.

An herb from the mint family, Salvia Divinorum has become a popular drug of choice with many Washington teenagers and its reported ability to make its users hallucinate and forget has many officials concerned, Seattle's KIRO-TV reported.

"Just because it's legal, just because it's not classified, just because it's not a controlled substance doesn't mean that it's healthy and safe," DEA official Rodney Benson said.

The herb, whose origins are in Mexican spiritual ceremonies, has already been linked to the suicide of a teen in Delaware, prompting officials there to ban the hallucinogen.

Benson said with the herb growing in popularity in the suburbs of Seattle, scientists are working quickly on determining if the herb should be deemed a controlled substance.

Until that decision can be made and authorities can act, Benson told the TV station area parents should inform their children of potential risks, including violent behavior and hallucinations.

Copyright 2007 by United Press International

Explore further: What's happening with your donated specimen?

add to favorites email to friend print save as pdf

Related Stories

Edible insects a boon to Thailand's farmers

Aug 25, 2014

Depending solely on the rains to either yield a good rice crop or leave their fields dry and barren, farmers in this village in northeastern Thailand, the country's poorest region, led a precarious and back-breaking ...

Taiwan evacuates 2,000 tourists as typhoon looms (Update)

Jul 11, 2013

Taiwan evacuated more than 2,000 tourists on Thursday as the island braced for super-typhoon Soulik, while Japan's Okinawa warned residents that giant waves of up to 12 metres (40 feet) could pound the archipelago.

Recommended for you

What's happening with your donated specimen?

7 hours ago

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.